Universal hepatitis B vaccination in adults aged 19–59 years: Updated recommendations of the advisory committee on immunization practices—United States, 2022

TY - JOUR

T1 - Universal hepatitis B vaccination in adults aged 19–59 years

T2 - Updated recommendations of the advisory committee on immunization practices—United States, 2022

AU - Weng, Mark K.

AU - Doshani, Mona

AU - Khan, Mohammed A.

AU - Frey, Sharon

AU - Ault, Kevin

AU - Moore, Kelly L.

AU - Hall, Eric W.

AU - Morgan, Rebecca L.

AU - Campos-Outcalt, Doug

AU - Wester, Carolyn

AU - Nelson, Noele P.

N1 - Funding Information: Aaron Harris; Andrew Leidner; Jessica MacNeil; Ismael Ortega‐Sanchez; Sarah Schillie; Joanna Taliano; Nicola D. Thompson; Shaoman Yin; Nida Ali, Laura Cooley, Lakshmi Panagiotakopoulos, PreHevbrio evidence review. Advisory Committee on Immunization Practices (ACIP): Grace Lee, Lucile Packard Children's Hospital, Chair; Melinda Wharton, National Center for Immunization and Respiratory Diseases, CDC, Executive Secretary; Members: Kevin Ault, University of Kansas Medical Center; Lynn Bahta, Minnesota Department of Health; Beth Bell, University of Washington; Oliver Brooks, Watts HealthCare Corporation; Wilbur Chen, University of Maryland School of Medicine; Sybil Cineas, The Warren Alpert Medical School of Brown University; Matthew Daley, Kaiser Permanente Colorado; Camille Kotton, Harvard Medical School; Sarah Long, Drexel University College of Medicine; Veronica McNally, Franny Strong Foundation; Katherine Poehling, Wake Forest School of Medicine; Pablo Sánchez, Research Institute at Nationwide Children's Hospital; Helen Keipp Talbot, Vanderbilt University; Ex Officio Members: John Beigel, National Institutes of Health; Doran Fink, Food and Drug Administration; Mary Beth Hance, Centers for Medicare & Medicaid Services; David Kim, Office of Infectious Disease and HIV/AIDS Policy, U.S. Department of Health and Human Services; Mary Rubin, Health Resources and Services Administration; Thomas Weiser, Indian Health Service; Liaison Representatives: Phyllis Arthur, Biotechnology Industry Organization; Sandra Adamson Fryhofer, American Medical Association; Carol Baker, Infectious Diseases Society of America; Elizabeth Barnett, International Society of Travel Medicine; Thevy Chai, American College Health Association; Rebecca Coyle, American Immunization Registry Association; Marci Drees, Society for Healthcare Epidemiology of America; Stephan Foster, American Pharmacists Association; Robert Gluckman, America's Health Insurance Plans; Jason Goldman, American College of Physicians; Stanley Grogg, American Osteopathic Association; Christine Hahn, Council of State and Territorial Epidemiologists; Carol Hayes, American College of Nurse Midwives; Molly Howell, Association of Immunization Managers; Marie‐Michèle Léger, American Academy of Physician Assistants; David Kimberlin, Bonnie Maldonado, American Academy of Pediatrics; W. Paul McKinney, Association for Prevention Teaching and Research; Amy Middleman, Society for Adolescent Health and Medicine; Linda O'Neal Eckert, American College of Obstetricians and Gynecologists; Sean O'Leary, Pediatric Infectious Diseases Society; Caroline Quach, Canadian National Advisory Committee on Immunization; Charles Rittle, American Nurses Association; Corey Robertson, Pharmaceutical Research and Manufacturers of America; Pamela Rockwell, American Academy of Family Physicians; William Schaffner, National Foundation for Infectious Diseases; Kenneth Schmader, American Geriatrics Society; Nirav Shah, Association of State and Territorial Health Officials; Patricia Stinchfield, National Association of Pediatric Nurse Practitioners; Patricia Whitley‐Williams, National Medical Association; Matthew Zahn, National Association of County and City Health Officials. ACIP Hepatitis Vaccines Work Group: Kevin Ault; Elizabeth Barnett; Sybil Cineas; Marci Drees; Susan Even; Darci Everett; Christine Finley; Robert Frenck; Sharon Frey; Prabhu Gounder; Kathleen Harriman; Brenna Hughes; Rajen Koshy; Susan Lett; Marian Major; Brian McMahon; Kelly Moore; David Nace; Pamela Rockwell; Jennifer Rosen; Ann Thomas; David Weber; Matthew Zahn; Jennifer Zipprich; CDC Lead: Mark K. Weng; Work Group Contributors: Erin E. Conners; Mona Doshani; Penina Haber; Megan Hofmeister; Neil Murthy; Noele P. Nelson; Lakshmi Panagiotakopoulos; Priti Patel; Philip Spradling; Carolyn Wester. All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. Kevin Ault reports grants received from the National Institutes of Health, consulting fees received from PathoVax, and leadership or fiduciary roles in American College of Obstetricians and Gynecologists, International Federation of Gynecology and Obstetrics, and Families Fighting Flu. Sharon Frey reports grants received from the National Institutes of Health and serving as chair of the HIV Vaccine Trials Network safety monitoring board. Eric W. Hall reports consulting fees from Merck for work unrelated to this manuscript. Kelly L. Moore reports that her employer receives unrestricted educational grant support from GlaxoSmithKline, Merck & Co., Inc., and a small unrestricted donation from Dynavax Technologies. No other potential conflicts of interest were disclosed.

PY - 2022/6

Y1 - 2022/6

UR - http://www.scopus.com/inward/record.url?scp=85131470940&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85131470940&partnerID=8YFLogxK

U2 - 10.1111/ajt.16661

DO - 10.1111/ajt.16661

M3 - Article

C2 - 35674154

AN - SCOPUS:85131470940

SN - 1600-6135

VL - 22

SP - 1714

EP - 1720

JO - American Journal of Transplantation

JF - American Journal of Transplantation

IS - 6

ER -